Skip to Job Description
International Consultant - Market Surveillance and Control (MSC) in the Western Pacific Region
World Health Organization (WHO)
WP/DHS Division of Health Systems and Services
Consultancy Internationallly Recruited
Close on 26 May 2026
Apply Now
Plan Next Steps
Posted 16 minutes ago
Job Description

Purpose of consultancy  

The Consultant will support Member States in preventing, detecting, and responding to substandard and falsified (SF) medical products, including in vitro diagnostics (IVDs) and other medical devices, through strengthened Global Surveillance and Monitoring System (GSMS) reporting, incident management, risk communication, risk-based post market surveillance (rbPMS) activities, and Quality Control Laboratory (QCL) enablement.


Background  

Substandard and falsified (SF) medical products pose a serious and growing threat to public health, undermining patient safety, health system confidence, and progress toward universal health coverage. SF medical products – including medicines, vaccines, in vitro diagnostics (IVDs), and medical devices – can lead to treatment failure, increased morbidity and mortality, antimicrobial resistance, and avoidable economic costs. To support Member States in addressing these risks, the World Health Organization (WHO) operates the Global Surveillance and Monitoring System (GSMS) for SF medical products, which enables the reporting, analysis, and sharing of information on suspected and confirmed incidents. Strengthening Member State engagement with the GSMS, alongside risk-based post market surveillance, laboratory enablement, inter sectoral coordination, and effective risk communication, is critical to enhancing early detection and response to SF medical products across the Western Pacific Region.


Deliverables

The Consultant is expected to complete the following outputs and deliverables:

Output 1: Technical support to Member States

Deliverable 1.1 Conduct rapid assessments of national market surveillance and SF medical product response systems in selected countries, including regulatory, laboratory, and enforcement linkages.
Deliverable 1.2 Support development and implementation of policies and strategies to prevent, detect and respond to SF medical products in the Pacific Island Countries.
Deliverable 1.3 Provide technical advice to national authorities on incident response pathways, including coordination between regulators, customs, law enforcement and laboratories. 
Deliverable 1.4 Support technical assistance to national quality control laboratories (NQCLs) in at least 2 countries, including through on-site visits, twinning programmes and peer-learning initiatives.

Output 2: Regional network and partnership coordination

Deliverable 2.1 Maintain collaboration with national regulatory authorities in the Western Pacific Region and laboratory networks, including the GSMS focal point (FP) network, WHO Global Network of Quality Control Laboratories for Pharmaceuticals (WHO-GNP), and the WHO Network of National Control Laboratories for Biologicals (WHO-NNB). 
Deliverable 2.2 Coordinate day‑to‑day FP engagement, onboarding, mentoring, and regional/subregional FP meetings.
Deliverable 2.3 Support joint activities with partners in official relations with WHO, including United Nations Office on Drugs and Crime (UNODC), World Customs Organization (WCO), World Organization for Animal Health (WOAH), Interpol, and academic laboratories. Support the development of an interagency strategy for collaboration on addressing SF medical products. 
Deliverable 2.4 Provide input into regional planning and reporting processes, ensuring timely and accurate documentation of activities and outcomes.  

Output 3: GSMS data cycle and analytics

Deliverable 3.1: Coordinate regional GSMS reporting and incident management related to SF medical products.
Deliverable 3.2: Produce localized threat assessment reports and thematic briefs for national authorities and the HQ and WPRO regulatory system strengthening teams.

Output 4: Training, Capacity building and Risk communication

Deliverable 4.1: Adapt and disseminate global risk communication (RC) tools to regional contexts; support country‑level RC plans and provide surge support during incidents. (supporting countries in responding to GSMS alerts). 
Deliverable 4.2: Contribute to the development, dissemination, and evaluation of training materials, guidance tools, and technical resources for SF medical products. 
 

Qualifications, experience, skills and languages

Educational Qualifications:  

Essential: University degree in pharmacy, pharmaceutical sciences, chemistry, biochemistry, microbiology, regulatory sciences, public health, or another relevant health or life sciences field from a recognized university.
Desirable: Advanced university degree (Master’s level) in pharmacy, pharmaceutical sciences, regulatory sciences, public health, quality assurance, laboratory sciences, or a related field from a recognized university.

Experience  

Essential: At least five years of professional experience in medical product market surveillance, post-marketing control, or pharmaceutical quality assurance, including demonstrated experience in strengthening regulatory systems, laboratory systems, or regulatory–laboratory interfaces.
Desirable: Practical knowledge of risk-based pharmaceutical quality surveillance, including product-defect reporting and investigation, use of incident or quality-defect data systems, and coordination with national quality control laboratories for for-cause testing and regulatory decision-making.

Skills/Knowledge:

Essential:

  • Strong analytical and communication skills
  • Information technology/data literacy (spreadsheets, dashboards, analytics)
  • Risk‑communication competencies
  • Stakeholder engagement

Languages and level required (Basic/Intermediate/Expert):

Essential: Expert knowledge of English (read, write, speak) 
Desirable: Basic knowledge of other languages spoken within the Western Pacific Region


Location

On site: WHO Regional Office for the Western Pacific – Manila, Philippines


Travel

The consultant may need to travel to selected countries in the Western Pacific Region. 
 

Remuneration and budget (travel costs are excluded):

a.       Remuneration: Payband level B – USD – 7,000 to 8,000 per month

b.       Living expenses: USD 2,100 per month

c.       Expected duration of contract:   6 months


Additional Information:

•     This vacancy notice may be used to identify candidates for other similar consultancies at the same level.
•     Only candidates under serious consideration will be contacted.
•     A written test may be used as a form of screening.
•     If your candidature is retained for interview, you will be required to provide, in advance, a scanned copy of the degree(s)/diploma(s)/certificate(s) required for this position. WHO only considers higher educational qualifications obtained from an institution accredited/recognized in the World Higher Education Database (WHED), a list updated by the International Association of Universities (IAU)/United Nations Educational, Scientific and Cultural Organization (UNESCO). The list can be accessed through the link: http://www.whed.net/. Some professional certificates may not appear in the WHED and will require individual review.
•     For information on WHO's operations please visit: http://www.who.int.
•     The WHO is committed to creating a diverse and inclusive environment of mutual respect. The WHO recruits workforce regardless of disability status, sex, gender identity, sexual orientation, language, race, marital status, religious, cultural, ethnic and socio-economic backgrounds, or any other personal characteristics. 
The WHO is committed to achieving gender parity and geographical diversity in its workforce. Women, persons with disabilities, and nationals of unrepresented and underrepresented Member States (https://www.who.int/careers/diversity-equity-and-inclusion) are strongly encouraged to apply for WHO jobs. 
Persons with disabilities can request reasonable accommodations to enable participation in the recruitment process. Requests for reasonable accommodation should be sent through an email to  reasonableaccommodation@who.int 
•     An impeccable record for integrity and professional ethical standards is essential. WHO prides itself on a workforce that adheres to the highest ethical and professional standards and that is committed to put the WHO Values Charter (https://www.who.int/about/who-we-are/our-values) into practice.
•     WHO has zero tolerance towards sexual exploitation and abuse (SEA), sexual harassment and other types of abusive conduct (i.e., discrimination, abuse of authority and harassment). All members of the WHO workforce have a role to play in promoting a safe and respectful workplace and should report to WHO any actual or suspected cases of SEA, sexual harassment and other types of abusive conduct. To ensure that individuals with a substantiated history of SEA, sexual harassment or other types of abusive conduct are not hired by the Organization, WHO will conduct a background verification of short-listed candidates.
•     WHO has a smoke-free environment and does not recruit smokers or users of any form of tobacco.
•     Consultants shall perform the work as independent contractors in a personal capacity, and not as a representative of any entity or authority. 
•     WHO shall have no responsibility for any taxes, duties, social security contributions or other contributions payable by the Consultant. The Consultant shall be solely responsible for withholding and paying any taxes, duties, social security contributions and any other contributions which are applicable to the Consultant in each location/jurisdiction in which the work hereunder is performed, and the Consultant shall not be entitled to any reimbursement thereof by WHO.
•     Please note that WHO’s contracts are conditional on members of the workforce confirming that they are vaccinated as required by WHO before undertaking a WHO assignment, except where a medical condition does not allow such vaccination, as certified by the WHO Staff Health and Wellbeing Services (SHW). The successful candidate will be asked to provide relevant evidence related to this condition. A copy of the updated vaccination card must be shared with WHO medical service in the medical clearance process. Please note that certain countries require proof of specific vaccinations for entry or exit. For example, official proof /certification of yellow fever vaccination is required to enter many countries. Country-specific vaccine recommendations can be found on the WHO international travel and Staff Health and Wellbeing website. For vaccination-related queries please directly contact SHW directly at shws@who.int.
•     In case the recruitment website does not display properly, please retry by: (i) checking that you have the latest version of the browser installed (Chrome, Edge or Firefox); (ii) clearing your browser history and opening the site in a new browser (not a new tab within the same browser); or (iii) retry accessing the website using Mozilla Firefox browser or using another device. Click the link for detailed guidance on completing job applications: Instructions for candidates.
 

{{waiting}}
This position is no longer open.